Vitros reagent and supplies

Ended Awarded Last action

Contract number
HT941026FE026
Awardee
Awarding agency
Obligated
$45,974

Award facts

Contract value 100% obligated
$45,974.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Japan

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$336
Original award $46,310

About this award

The Defense Health Agency issued a BPA call to Ortho Clinical Diagnostics K.K. on February 2, 2026, for VITROS reagent and supplies, with a ceiling value of $45,974.02 and completion date of February 15, 2026. The call is issued under a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $250,000, awarded October 1, 2025, through September 30, 2030, for laboratory medical supplies supporting the Medical Department Activity in Japan. Performance occurs in Japan. The order is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract HT941026FE026?

HT941026FE026 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on February 2, 2026.

How much is contract HT941026FE026 worth?

The government has obligated $45,974 on HT941026FE026.

Is contract HT941026FE026 an order under another contract?

Yes. HT941026FE026 is a BPA call under HT941024A0007, a blanket purchase agreement.

Was contract HT941026FE026 competed?

The extent of competition for HT941026FE026 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award